Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132971) titled 'Using Artificial Intelligence to Analyze Ultrasound and Mammography Images for Distinguishing Benign from Malignant BI-RADS Category 4 Breast Lesions' on Sept. 20.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Affiliated Qingyuan Hospital, Guangzhou Medical University (Qingyuan People's Hospital)

Condition: BI-RADS category 4 breast lesions

Intervention: Group 1:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-20

Target Sample Size: Group 1:385;Group 2:165;

Countries of Recruitment: China

To know more, visit https://www.chictr.org...